Carlos Sanchez Soto, MD
Interventional Cardiology · Columbus, OHNPI 1023277043
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Medtronic at 37.6% of the total. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,949 payments — averaging $572.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$419K
- Edwards Lifesciences$170K
- Siemens Medical Solutions USA, Inc.$123K
- Boston Scientific$116K
- Philips North America LLC$98K
- Abbott$96K
- plus $93K from 24 others
Across 177 payments — averaging $3605.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$378K
- Edwards Lifesciences$147K
- Boston Scientific$67K
- Cardiovascular Systems Inc.$39K
- Medtronic$6K
What the payments were for
- Consulting fees$390,29435%
- Speaking & faculty fees$555,23150%
- Travel & lodging$123,46711%
- Food & beverage$45,8404%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 1,082 | $419,200 |
| Edwards Lifesciences | 159 | $169,759 |
| Siemens Medical Solutions USA, Inc. | 110 | $122,777 |
| Boston Scientific | 174 | $115,799 |
| Philips North America LLC | 92 | $98,233 |
| Abbott | 188 | $95,802 |
| Biosense Webster, Inc. | 39 | $52,427 |
| Shockwave Medical, Inc | 14 | $32,140 |
| Livanova USA, Inc. | 5 | $2,784 |
| Biotrace Medical, Inc. | 2 | $1,500 |
| Medical Device Business Services, Inc. | 1 | $1,350 |
| Biotronik Inc. | 44 | $737 |
| Angiodynamics, Inc. | 2 | $460 |
| Jenavalve Technology, Inc. | 1 | $257 |
| E.r. Squibb & Sons, L.L.C. | 6 | $236 |
| Abiomed | 2 | $221 |
| Centerline Biomedical Inc. | 1 | $173 |
| Cardiovascular Systems Inc. | 2 | $163 |
| ZOLL Circulation Inc | 1 | $150 |
| Amgen | 3 | $134 |
| Johnson & Johnson | 4 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $121 |
| Pfizer | 5 | $93 |
| Neovasc Medical Inc | 1 | $75 |
| Novo Nordisk | 4 | $68 |
| Cook Medical LLC | 2 | $30 |
| AstraZeneca | 1 | $12 |
| Cardinal Health 200 LLC | 1 | $11 |
| Croivalve Inc | 1 | $10 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$171,490
- Edwards SAPIEN 3 Transcatheter Heart Valve$154,189
- CoreValve Evolut$130,164
- (9520) IGT Devices Undivided$86,078
- ACUSON SC2000 Diagnostic Ultrasound System$80,948
- Watchman$40,326
- MitraClip$39,419
- MitraClip System$32,454
- Carto 3$31,127
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$25,873
- APOLLOTM$24,227
- ACUSON Origin Diagnostic Ultrasound System$21,019
- GENERAL - STRUCTURAL HEART$18,152
- Mitra Clip system$15,527
- GENERAL - THERAPIES$11,943
- PASCAL$9,290
- Carto 3 System$8,550
- Resolute$7,401
- VersaCross Access Solution$7,391
- Vascular Lithotripsy$6,162
How this compares
$1,114,849 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $14,681 |
| Ranolazine ErRanolazine | 13 | $691 |
| Atorvastatin Calcium | 69 | $572 |
| ClopidogrelClopidogrel Bisulfate | 34 | $360 |
| Metoprolol Tartrate | 22 | $193 |
| Amlodipine Besylate | 18 | $157 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 19 | $119 |
| Carvedilol | 17 | $88 |
| Lisinopril | 21 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $93 | $14,68119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Steven YakubovColumbus$907K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- Michael JollyColumbus$281K
- Timothy SmithColumbus$149K
- Christopher HuffColumbus$119K
- Joseph CampbellColumbus$114K
- Aref AmroColumbus$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.